KEI statement on GSK’s announcement of policies to expand access to patented medicines
GSK has made a major announcement of new policies to expand access to its patented medicines. A copy of the press statement is here. Continue Reading
Intellectual Property Rights
16 groups write open letter to WHO Director-General Dr Tedros: Roadmap on Access to Medicines and Vaccines 2019-2023
On Friday, 3 August 2018, 16 groups sent an open letter to WHO Director-General, Dr Tedros Adhanom Ghebreyesus expressing views on the proposed WHO Roadmap on Access to Medicines and Vaccines 2019-2023. The letter requested the Director-General to strengthen activities… Continue Reading
Secretary Alex Azar’s comment on 28 USC 1498 submitted for the record of the 2018 confirmation hearings
The following is a question for the record from Senator Sherrod Brown, and a response from Alex Azar, in connection with Azar’s confirmation hearing. Questions for the Record January 9, 2018 Hearing to Consider the Nomination of Alex Azar to… Continue Reading
South Africa breaks the silence procedure: UN Political Declaration on tuberculosis
On 26 September 2018, the United Nations’ General Assembly will convene the first high-level meeting on tuberculosis; the theme of the meeting is “United to end tuberculosis: an urgent global response to a global epidemic”. In preparation for the United… Continue Reading
As Pandemic Preparedness bill clears House committee, effort to include antibiotics transferable exclusivity extension fails
On July 18, 2018, the U.S. House Energy and Commerce committee gave its approval to HR 6378, the Pandemic and All-Hazards Preparedness Act, known as PAHPA. During the mark up, Reps. John Shimkus (R-IL) and Tony Cárdenas (D-CA) proposed attaching… Continue Reading
SCP28: Final text on future work mandates the preparation of a draft reference document on compulsory licensing
At around 16h35 on Thursday, 12 July 2018, the WIPO Secretariat distributed the final text of the future work program of the Standing Committee on the Law of Patents (SCP). The final text can be found here: http://www.wipo.int/edocs/mdocs/scp/en/scp_28/scp_28_11.pdf The new… Continue Reading
SCP28: Chair’s text (version 1) on future work mandates the sharing of state practice on compulsory licensing of medical technologies and transparency of medical patents
Geneva 15h56 On Thursday, 12 July 2018, at the 28th session of the Standing Committee on the Law of Patents (SCP) countries are negotiating over the mandate of WIPO’s future work program on a suite of issues including: 1) Exceptions… Continue Reading
SCP28: KEI intervention on patents and health
On 11 July 2018, Knowledge Ecology International delivered the following statement on patents and health at the 28th session of WIPO’s Standing Committee on the Law of Patents (SCP). Statement of Knowledge Ecology International Agenda item 7 – Patents and… Continue Reading
SCP28: KEI statement on Exceptions and limitations to patent rights
On Monday, 9 July 2018, Knowledge Ecology International (KEI) made the following statement on exceptions and limitations to patent rights. KEI made the following proposal: In terms of future work on this item on exceptions and limitations to patent rights,… Continue Reading
SCP28: Opening statement of the Asia & the Pacific Group
On 9 July 2018, Indonesia delivered this opening statement on behalf of the Asia & the Pacific Group at the 28th session of the WIPO Standing Committee on the Law of Patents (SCP). Opening Statement by the Republic of Indonesia… Continue Reading
WHO publishes Meeting Report of the Informal Advisory Group on the Availability and Affordability of Cancer Medicines
In May 2017, the 70th World Health Assembly passed a cancer resolution (WHA70.12, Cancer prevention and control in the context of an integrated approach). At the time KEI provided the following commentary on the cancer resolution: On Tuesday, May 30,… Continue Reading